Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
Clinical trial NCT06367088 · RECRUITING
Trial details
- NCT number
- NCT06367088
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-04-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.